Furthermore, several studies demonstrated increased levels of IL-17 and GM-CSF in peripheral blood and tears of patients with COVID-19, and a higher fraction of Th17 cells in the site of infection—in bronchoalveolar lavage fluid [43,46]. The gene discussed is IL17A; the disease is COVID-19.